Ikarian Capital’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 118 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 140 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 138 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 113 |
|
|
2022
Q2 | – | Sell |
-510,126
| Closed | -$837K | – | 116 |
|
|
2022
Q1 | $837K | Buy |
510,126
+27,516
| +6% | +$45.1K | 0.11% | 72 |
|
|
2021
Q4 | $1.16M | Sell |
482,610
-274,935
| -36% | -$663K | 0.17% | 66 |
|
|
2021
Q3 | $3.67M | Buy |
757,545
+657,545
| +658% | +$3.18M | 0.26% | 38 |
|
|
2021
Q2 | $267K | Hold |
100,000
| – | – | 0.02% | 146 |
|
|
2021
Q1 | $307K | Buy |
+100,000
| New | +$307K | 0.01% | 154 |
|